Opportunistic infections after blood and marrow transplantation
- 1 March 1999
- journal article
- review article
- Published by Wiley in Transplant Infectious Disease
- Vol. 1 (1), 3-20
- https://doi.org/10.1034/j.1399-3062.1999.10102.x
Abstract
Opportunistic infections are major causes of morbidity and mortality following bone marrow transplantation. Technological advances in stem cell procurement, the introduction of hematologic growth factors to speed engraftment, the development of new immunosuppressive regimens to control graft‐versus‐host disease (GVHD), the development of technology to perform graft engineering with removal of T lymphocytes in toto or subpopulations of T lymphocytes, the use of molecular techniques to optimize donor and recipient matching, advances in blood banking, and development of international donor registries, are among the various factors that have led to tremendous changes in transplant practices. Because of such changes in transplant practices, along with the advent of new antimicrobial agents, and development of infection control measures affecting pathogen exposure, alterations in the interplay between host and potential pathogens have occurred. Shifts in the incidence and types of opportunistic pathogens are taking place. Several historically important infectious syndromes are today well controlled; others have diminished in importance early after transplant but are more problematic at a later time; new emerging pathogens are being recognized due to selection pressures from antimicrobial usage and new hosts, such as recipients of alternate donor allogeneic transplant procedures, with even more profound and prolonged immune suppression. Such shifts and new syndromes pose continuing new challenges to the transplant clinician ( Note).Keywords
This publication has 118 references indexed in Scilit:
- Bone Marrow Transplants from Unrelated Donors for Patients with Chronic Myeloid LeukemiaNew England Journal of Medicine, 1998
- A Controlled Trial of Fluconazole to Prevent Fungal Infections in Patients Undergoing Bone Marrow TransplantationNew England Journal of Medicine, 1992
- Acyclovir for Prevention of Cytomegalovirus Infection and Disease after Allogeneic Marrow TransplantationNew England Journal of Medicine, 1988
- Association of BK Viruria with Hemorrhagic Cystitis in Recipients of Bone Marrow TransplantsNew England Journal of Medicine, 1986
- Cytomegalovirus Immune Globulin and Seronegative Blood Products to Prevent Primary Cytomegalovirus Infection after Marrow TransplantationNew England Journal of Medicine, 1986
- Epstein–Barr Virus–Associated B-Cell Proliferations of Diverse Clonal Origins after Bone Marrow Transplantation in a 12-Year-Old Patient with Severe Combined ImmunodeficiencyNew England Journal of Medicine, 1985
- Adenovirus Infections in Patients Undergoing Bone-Marrow TransplantationNew England Journal of Medicine, 1985
- Cytotoxic T Cells in Cytomegalovirus InfectionNew England Journal of Medicine, 1982
- Acyclovir Prophylaxis of Herpes-Simplex-Virus InfectionsNew England Journal of Medicine, 1981
- An outbreak of aspergillosis in children with acute leukemiaThe Journal of Pediatrics, 1979